Article
Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross
20 Sept 2019
Abstract excerpt
Mainstay treatment for Plasmodium vivax malaria has long relied on chloroquine (CQ) against blood-stage parasites plus primaquine against dormant liver-stage forms (hypnozoites), however drug resistance confronts this regimen and threatens malaria control programs. Understanding the basis of P. vivax chloroquine resistance (CQR) will inform drug discovery and malaria control. Here we investigate the genetics of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
